Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States based on the number of facilities. Our reportable segments include the critical illness recovery hospital segment, the rehabilitation hospital segment, the outpatient rehabilitation segment, and the Concentra segment. As of March 31, 2019, Select Medical operated 97 critical illness recovery hospitals in 28 states, 27 rehabilitation hospitals in 11 states, and 1,684 outpatient rehabilitation clinics in 37 states and the District of Columbia. Select Medical's joint venture subsidiary Concentra operated 525 occupational health centers in 41 states. Concentra also provides contract services at employer worksites and Department of Veterans Affairs community-based outpatient clinics. At March 31, 2019, Select Medical had operations in 47 states and the District of Columbia.
Company profile
Ticker
SEM
Exchange
Website
CEO
David S. Chernow
Employees
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Actra Rehabilitation Associates, Inc. • Acuity General Partner, LLC • Acuity Healthcare Holdings, Inc. • Acuity Healthcare Management, LLC • Acuity Healthcare of Ohio, L.L.C. • Acuity Healthcare, LP • Acuity Holdings, LLC • Acuity Hospital of New Jersey, L.L.C. • Acuity Specialty Hospital—Ohio Valley, LP • Acuity Specialty Hospital, LLC ...
SEM stock data
Analyst ratings and price targets
Latest filings (excl ownership)
8-K
Select Medical Holdings Corporation Announces Results
3 Nov 22
10-Q
2022 Q3
Quarterly report
3 Nov 22
8-K
Select Medical Holdings Corporation Announces Results
4 Aug 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
8-K
Departure of Directors or Certain Officers
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
8-K
Select Medical Holdings Corporation Announces Results
5 May 22
8-K
Submission of Matters to a Vote of Security Holders
29 Apr 22
8-K
Regulation FD Disclosure
4 Mar 22
DEFA14A
Additional proxy soliciting materials
4 Mar 22
Transcripts
SEM
Earnings call transcript
2022 Q3
4 Nov 22
SEM
Earnings call transcript
2022 Q2
5 Aug 22
SEM
Earnings call transcript
2022 Q1
6 May 22
SEM
Earnings call transcript
2021 Q4
25 Feb 22
SEM
Earnings call transcript
2020 Q3
30 Oct 20
SEM
Earnings call transcript
2020 Q2
31 Jul 20
SEM
Earnings call transcript
2020 Q1
1 May 20
SEM
Earnings call transcript
2019 Q4
21 Feb 20
SEM
Earnings call transcript
2019 Q3
1 Nov 19
SEM
Earnings call transcript
2019 Q2
2 Aug 19
Latest ownership filings
Financial summary
| Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 108.22 mm | 108.22 mm | 108.22 mm | 108.22 mm | 108.22 mm | 108.22 mm |
| Cash burn (monthly) | (no burn) | 53.31 mm | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | n/a | 219.85 mm | n/a | n/a | n/a | n/a |
| Cash remaining | n/a | -111.63 mm | n/a | n/a | n/a | n/a |
| Runway (months of cash) | n/a | -2.1 | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2022
76.3% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 209 |
| Opened positions | 27 |
| Closed positions | 29 |
| Increased positions | 64 |
| Reduced positions | 89 |
| 13F shares | Current |
|---|---|
| Total value | 2.36 bn |
| Total shares | 96.89 mm |
| Total puts | 18.20 k |
| Total calls | 0.00 |
| Total put/call ratio | Infinity |
| Largest owners | Shares | Value |
|---|---|---|
| T. Rowe Price | 19.45 mm | $429.78 mm |
| BLK Blackrock | 16.55 mm | $365.77 mm |
| Vanguard | 11.68 mm | $258.23 mm |
| T. Rowe Price Investment Management | 6.38 mm | $140.98 mm |
| LSV Asset Management | 5.47 mm | $120.87 mm |
| Camber Capital Management | 4.80 mm | $106.08 mm |
| Dimensional Fund Advisors | 4.64 mm | $102.53 mm |
| BK Bank Of New York Mellon | 2.13 mm | $47.10 mm |
| PFG Principal Financial Group Inc - Registered Shares | 2.11 mm | $46.71 mm |
| IVZ Invesco | 1.98 mm | $43.74 mm |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Nov 22 | Cressey Bryan C | Common Stock | Grant | Acquire A | No | No | 26.13 | 689 | 18.00 k | 73,602 |
| 1 Nov 22 | James S. Ely III | Common Stock | Grant | Acquire A | No | No | 26.13 | 689 | 18.00 k | 125,022 |
| 1 Nov 22 | Frist William H. | Common Stock | Grant | Acquire A | No | No | 26.13 | 689 | 18.00 k | 260,617 |
| 1 Nov 22 | Parvinderjit S. Khanuja | Common Stock | Grant | Acquire A | No | No | 26.13 | 689 | 18.00 k | 19,172 |
| 31 Oct 22 | Thomas P Mullin | Common Stock | Payment of exercise | Dispose F | No | No | 25.68 | 11,020 | 282.99 k | 230,292 |